• Featured Product
  • KD/KO Validated

STK17A Polyclonal antibody

STK17A Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

Cat no : 14433-1-AP

Synonyms

DRAK1, serine/threonine kinase 17a, STK17A



Tested Applications

Positive WB detected inBxPC-3 cells, human skeletal muscle tissue, mouse skeletal muscle tissue, NIH/3T3 cells
Positive IHC detected inhuman heart tissue, human placenta tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:3000
Immunohistochemistry (IHC)IHC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

14433-1-AP targets STK17A in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen STK17A fusion protein Ag5811
Full Name serine/threonine kinase 17a
Calculated Molecular Weight 47 kDa
Observed Molecular Weight 47-53 kDa
GenBank Accession NumberBC047696
Gene Symbol STK17A
Gene ID (NCBI) 9263
RRIDAB_10858629
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for STK17A antibody 14433-1-APDownload protocol
IHC protocol for STK17A antibody 14433-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Mol Med Rep

Prognostic and predictive roles of microRNA‑411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer.

Authors - Wei Wei
  • KD Validated